Table 3 Artemisinin derivatives known by medical practitioners in urban zones
Artemisinin derivatives | Medical practitioners (n = 132), Percent |
|---|---|
Informed (n = 125) | |
Monotherapies | |
Artesunate suppositories | (56) 42.4 |
Dihydroartemisinin | (26) 19.7 |
Artemether | (11) 8.3 |
Bitherapies (ACT) | |
Artesunate-mefloquine | (13) 9.9 |
Artemether-lumefantrine | (10) 7.6 |
Artesunate-amodiaquine | (9) 6.8 |
Not informed (n = 7) |